IVBH Bio
Company Details
Status: Private
Employees: 1-10
Location:
Newport Beach, California, United States
Type:
sample
Technology:
sample
About: We are on a mission to create the next century’s worth of impact on human health, starting with early detection.
Since our founding in 2018, we have been operating at the convergence of artificial intelligence, transcriptomics and liquid biopsy — applying the most advanced compute to the most fundamental language of the human cell to create the world’s most advanced early detection blood tests.
Our disease-agnostic platform is revolutionizing healthcare diagnostics, providing a reliable and scalable approach to solving real-world problems for pandemic diseases, from oncology to metabolic health.
To date, our brain trust of visionary entrepreneurs and world-class scientists and technologists have conceived, created and scaled three pioneering early detection companies — @mammogen, @liquidlung & @hepgene — leveraging our novel end-to-end AI-powered platform to usher in a new era of clinical assays capable of detecting early-stage disease with unprecedented accuracy, affordability and accessibility.
To learn more about us visit IVBH.studio or send us a note at info@IVBH.studio.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
IVBH Bio | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.